Return to site
Return to site

Singleron Completes $30 Million Series A Financing

broken image

09/06/2020 – Singleron Biotechnologies, a Chinese start-up developing high-throughput single-cell multiomics platform products, announced the successful completion of $30 million Series A financing. Lilly Asia Ventures (LAV) led the investment. Other new investors include CDH Investments, ARCH Venture Partners, Tencent, and China Reform Conson Soochow Overseas Fund I L.P. (managed by CDG Capital). Existing investors Sherpa Healthcare Partners and China Growth Capital also participated in this funding round.

 

Founded in 2018, Singleron has dedicated to applying groundbreaking single cell analysis technologies to clinical diagnosis, drug development and health management. The company currently has offices and laboratories in Nanjing, Suzhou, US and Germany. Singleron will invest the proceeds to further develop single-cell platform products and their clinical applications, to accelerate the commercialization of its proprietary technologies, and to ramp up its international presence.

 

This A round is Singleron's third round of financing after the seed round and Pre-A round led by Oriza Seed and Sherpa Healthcare Partners in 2018 and 2019, respectively. To date the total funding received by Singleron has exceeded 300 million yuan.

Previous
Sansure Biotech Debuts on STAR Market
Next
InventisBio Completes $147 Million Series D Financing
 Return to site
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
Necessary Cookies
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
Analytics Cookies
These cookies help us better understand how visitors interact with our website and help us discover errors.
Preferences Cookies
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save